FAIR VALUE (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis |
The following tables present the assets and liabilities that are measured at fair value on a recurring and nonrecurring basis by major product category and fair value hierarchy as of the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Level 1 | | Level 2 | | Level 3 | | Balance at September 30, 2026 | | Level 1 | | Level 2 | | Level 3 | | Balance at December 31, 2025 | | Recurring: | | | | | | | | | | | | | | | | | | Financial assets: | | | | | | | | | | | | | | | | | | U.S. Treasury securities | | $ | 226 | | | $ | — | | | $ | — | | | $ | 226 | | | $ | 706 | | | $ | — | | | $ | — | | | $ | 706 | | | Corporate debt | | — | | | 9 | | | — | | | 9 | | | — | | | — | | | — | | | — | | | ABS | | — | | | 2,037 | | | — | | | 2,037 | | | — | | | 945 | | | — | | | 945 | | Beneficial interest in Structured LLC | | — | | | — | | | 1,013 | | | 1,013 | | | — | | | — | | | 1,097 | | | 1,097 | | | | | | | | | | | | | | | | | | | | MBS | | — | | | 6,378 | | | — | | | 6,378 | | | — | | | 4,580 | | | — | | | 4,580 | | Investment in debt securities AFS (2) | | $ | 226 | | | $ | 8,424 | | | $ | 1,013 | | | $ | 9,663 | | | $ | 706 | | | $ | 5,525 | | | $ | 1,097 | | | $ | 7,328 | | | Trading securities | | 2,851 | | | 14,870 | | | 112 | | | 17,833 | | | 3,539 | | | 11,897 | | | 173 | | | 15,609 | | | Equity securities | | 41 | | | — | | | 890 | | | 931 | | | — | | | — | | | 992 | | | 992 | | | | | | | | | | | | | | | | | | | RICs HFI (3) | | — | | | — | | | 3 | | | 3 | | | — | | | — | | | 5 | | | 5 | | LHFS (1)(4) | | — | | | 1,685 | | | — | | | 1,685 | | | — | | | 1,531 | | | — | | | 1,531 | | | MSRs | | — | | | — | | | 83 | | | 83 | | | — | | | — | | | 80 | | | 80 | | Other assets - derivatives (2) | | 1 | | | 1,740 | | | — | | | 1,741 | | | 1 | | | 671 | | | — | | | 672 | | Total financial assets (5) | | $ | 3,119 | | | $ | 26,719 | | | $ | 2,101 | | | $ | 31,939 | | | $ | 4,246 | | | $ | 19,624 | | | $ | 2,347 | | | $ | 26,217 | | | Financial liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trading liabilities | | 3,848 | | | 177 | | | — | | | 4,025 | | | 3,728 | | | 274 | | | — | | | 4,002 | | Other liabilities - derivatives (2) | | — | | | 1,529 | | | 1 | | | 1,530 | | | — | | | 648 | | | 1 | | | 649 | | | Total financial liabilities | | $ | 3,848 | | | $ | 1,706 | | | $ | 1 | | | $ | 5,555 | | | $ | 3,728 | | | $ | 922 | | | $ | 1 | | | $ | 4,651 | | | Nonrecurring: | | | | | | | | | | | | | | | | | | Financial assets: | | | | | | | | | | | | | | | | | | Impaired commercial LHFI | | $ | — | | | $ | 361 | | | $ | 454 | | | $ | 815 | | | $ | — | | | $ | 213 | | | $ | 3 | | | $ | 216 | | | Foreclosed assets | | — | | | 28 | | | — | | | 28 | | | — | | | 32 | | | — | | | 32 | | | Vehicle inventory | | — | | | 371 | | | — | | | 371 | | | — | | | 379 | | | — | | | 379 | | | LHFS | | — | | | — | | | 288 | | | 288 | | | — | | | — | | | 55 | | | 55 | | | Auto loans impaired due to bankruptcy | | — | | | 171 | | | — | | | 171 | | | — | | | 168 | | | — | | | 168 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total financial assets valued at fair value on a non-recurring basis | | $ | — | | | $ | 931 | | | $ | 742 | | | $ | 1,673 | | | $ | — | | | $ | 792 | | | $ | 58 | | | $ | 850 | |
(1) LHFS disclosed on the Condensed Consolidated Balance Sheets also includes LHFS that are held at the lower of cost or fair value and are presented within the nonrecurring section of this table. (2) Refer to Note 2 for the fair value of investment securities and to Note 13 for the fair values of derivative assets and liabilities on a further disaggregated basis. (3) Certain RICs collateralized by vehicle titles and RV/marine loans. (4) Residential mortgage loans and commercial mortgage loans. (5) Approximately $2.1 billion of these financial assets were measured using model-based techniques, or Level 3 inputs, and represented approximately 6.6% of total assets measured at fair value on a recurring basis and approximately 0.8% of total consolidated assets.
|
| Schedule of Rollforward for Assets and Liabilities Measured at Fair Value on a Recurring Basis |
The tables below present the changes in Level 3 balances for those assets and liabilities measured at fair value on a recurring basis for the periods indicated. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, 2026 | | Three months ended September 30, 2025 | | | | (in millions) | | Beneficial Interest in Structured LLC | | RICs HFI | | MSRs | | Derivatives, net | | Equity Securities | | Trading Securities | | Total | | Beneficial interest in Structured LLC | | RICs HFI | | MSRs | | Derivatives, net | | Equity Securities | | Trading Securities | | Total | | | | Balances, beginning of period | | $ | 1,056 | | | $ | 3 | | | $ | 79 | | | $ | (1) | | | $ | 928 | | | $ | 111 | | | $ | 2,176 | | | $ | 1,118 | | | $ | 7 | | | $ | 82 | | | $ | — | | | $ | — | | | $ | 156 | | | $ | 1,363 | | | | | Gains / (losses) in OCI | | (43) | | | — | | | — | | | — | | | — | | | — | | | (43) | | | (10) | | | — | | | — | | | — | | | — | | | — | | | (10) | | | | | Gains/(losses) in earnings | | — | | | — | | | 6 | | | — | | | (3) | | | 4 | | | 7 | | | — | | | — | | | 2 | | | (1) | | | — | | | (6) | | | (5) | | | | | Additions/Issuances | | — | | | — | | | 1 | | | — | | | — | | | 1 | | | 2 | | | — | | | — | | | — | | | — | | | 832 | | | 10 | | | 842 | | | | | Transfers from Level 2 | | — | | | — | | | — | | | — | | | — | | | 6 | | | 6 | | | — | | | — | | | — | | | — | | | — | | | 68 | | | 68 | | | | | Transfers from Level 3 | | — | | | — | | | — | | | — | | | (41) | | | — | | | (41) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | | Settlements(1) | | — | | | — | | | (3) | | | — | | | 6 | | | (10) | | | (7) | | | (10) | | | (1) | | | (3) | | | — | | | — | | | (22) | | | (36) | | | | | Balances, end of period | | $ | 1,013 | | | $ | 3 | | | $ | 83 | | | $ | (1) | | | $ | 890 | | | $ | 112 | | | $ | 2,100 | | | $ | 1,098 | | | $ | 6 | | | $ | 81 | | | $ | (1) | | | $ | 832 | | | $ | 206 | | | $ | 2,222 | | | | | Changes in unrealized gains (losses) included in earnings related to balances still held at end of period | | $ | — | | | $ | — | | | $ | 6 | | | $ | — | | | $ | (23) | | | $ | 4 | | | $ | (13) | | | $ | — | | | $ | — | | | $ | 2 | | | $ | (1) | | | $ | — | | | $ | (6) | | | $ | (5) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine months ended September 30, 2026 | | Nine months ended September 30, 2025 | | | | (in millions) | | Beneficial Interest in Structured, LLC | | RICs HFI | | MSRs | | Derivatives, net | | Equity Securities | | Trading Securities | | Total | | Beneficial interest in Structured, LLC | | RICs HFI | | MSRs | | Derivatives, net | | Equity Securities | | Trading Securities | | Total | | | | Balances, beginning of period | | $ | 1,097 | | | $ | 5 | | | $ | 80 | | | $ | (1) | | | $ | 992 | | | $ | 173 | | | $ | 2,346 | | | $ | 1,199 | | | $ | 9 | | | $ | 91 | | | $ | — | | | $ | — | | | $ | 6 | | | $ | 1,305 | | | | | Gain / (losses) in OCI | | (56) | | | — | | | — | | | — | | | — | | | — | | | (56) | | | (81) | | | — | | | — | | | — | | | — | | | — | | | (81) | | | | | Gains/(losses) in earnings | | — | | | — | | | 10 | | | — | | | (20) | | | 2 | | | (8) | | | — | | | — | | | (3) | | | (1) | | | — | | | (6) | | | (10) | | | | | Additions/Issuances | | — | | | — | | | 1 | | | — | | | — | | | 6 | | | 7 | | | — | | | — | | | — | | | — | | | 832 | | | 10 | | | 842 | | | | | Transfers from Level 2 | | — | | | — | | | — | | | — | | | — | | | 6 | | | 6 | | | — | | | — | | | — | | | — | | | — | | | 220 | | | 220 | | | | | Transfers from Level 3 | | — | | | — | | | — | | | — | | | (41) | | | — | | | (41) | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | | Settlements (1) | | (28) | | | (2) | | | (8) | | | — | | | (41) | | | (75) | | | (154) | | | (20) | | | (3) | | | (7) | | | — | | | — | | | (24) | | | (54) | | | | | Balances, end of period | | $ | 1,013 | | | $ | 3 | | | $ | 83 | | | $ | (1) | | | $ | 890 | | | $ | 112 | | | $ | 2,100 | | | $ | 1,098 | | | $ | 6 | | | $ | 81 | | | $ | (1) | | | $ | 832 | | | $ | 206 | | | $ | 2,222 | | | | | Changes in unrealized gains (losses) included in earnings related to balances still held at end of period | | $ | — | | | $ | — | | | $ | 10 | | | $ | — | | | $ | (58) | | | $ | 2 | | | $ | (46) | | | $ | — | | | $ | — | | | $ | (3) | | | $ | (1) | | | $ | — | | | $ | (6) | | | $ | (10) | | | |
(1)Settlements include charge-offs, prepayments, paydowns, sales, and maturities.
|
| Schedule of Assets Measured at Fair Value on a Nonrecurring Basis |
The following tables present the assets and liabilities that are measured at fair value on a recurring and nonrecurring basis by major product category and fair value hierarchy as of the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Level 1 | | Level 2 | | Level 3 | | Balance at September 30, 2026 | | Level 1 | | Level 2 | | Level 3 | | Balance at December 31, 2025 | | Recurring: | | | | | | | | | | | | | | | | | | Financial assets: | | | | | | | | | | | | | | | | | | U.S. Treasury securities | | $ | 226 | | | $ | — | | | $ | — | | | $ | 226 | | | $ | 706 | | | $ | — | | | $ | — | | | $ | 706 | | | Corporate debt | | — | | | 9 | | | — | | | 9 | | | — | | | — | | | — | | | — | | | ABS | | — | | | 2,037 | | | — | | | 2,037 | | | — | | | 945 | | | — | | | 945 | | Beneficial interest in Structured LLC | | — | | | — | | | 1,013 | | | 1,013 | | | — | | | — | | | 1,097 | | | 1,097 | | | | | | | | | | | | | | | | | | | | MBS | | — | | | 6,378 | | | — | | | 6,378 | | | — | | | 4,580 | | | — | | | 4,580 | | Investment in debt securities AFS (2) | | $ | 226 | | | $ | 8,424 | | | $ | 1,013 | | | $ | 9,663 | | | $ | 706 | | | $ | 5,525 | | | $ | 1,097 | | | $ | 7,328 | | | Trading securities | | 2,851 | | | 14,870 | | | 112 | | | 17,833 | | | 3,539 | | | 11,897 | | | 173 | | | 15,609 | | | Equity securities | | 41 | | | — | | | 890 | | | 931 | | | — | | | — | | | 992 | | | 992 | | | | | | | | | | | | | | | | | | | RICs HFI (3) | | — | | | — | | | 3 | | | 3 | | | — | | | — | | | 5 | | | 5 | | LHFS (1)(4) | | — | | | 1,685 | | | — | | | 1,685 | | | — | | | 1,531 | | | — | | | 1,531 | | | MSRs | | — | | | — | | | 83 | | | 83 | | | — | | | — | | | 80 | | | 80 | | Other assets - derivatives (2) | | 1 | | | 1,740 | | | — | | | 1,741 | | | 1 | | | 671 | | | — | | | 672 | | Total financial assets (5) | | $ | 3,119 | | | $ | 26,719 | | | $ | 2,101 | | | $ | 31,939 | | | $ | 4,246 | | | $ | 19,624 | | | $ | 2,347 | | | $ | 26,217 | | | Financial liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Trading liabilities | | 3,848 | | | 177 | | | — | | | 4,025 | | | 3,728 | | | 274 | | | — | | | 4,002 | | Other liabilities - derivatives (2) | | — | | | 1,529 | | | 1 | | | 1,530 | | | — | | | 648 | | | 1 | | | 649 | | | Total financial liabilities | | $ | 3,848 | | | $ | 1,706 | | | $ | 1 | | | $ | 5,555 | | | $ | 3,728 | | | $ | 922 | | | $ | 1 | | | $ | 4,651 | | | Nonrecurring: | | | | | | | | | | | | | | | | | | Financial assets: | | | | | | | | | | | | | | | | | | Impaired commercial LHFI | | $ | — | | | $ | 361 | | | $ | 454 | | | $ | 815 | | | $ | — | | | $ | 213 | | | $ | 3 | | | $ | 216 | | | Foreclosed assets | | — | | | 28 | | | — | | | 28 | | | — | | | 32 | | | — | | | 32 | | | Vehicle inventory | | — | | | 371 | | | — | | | 371 | | | — | | | 379 | | | — | | | 379 | | | LHFS | | — | | | — | | | 288 | | | 288 | | | — | | | — | | | 55 | | | 55 | | | Auto loans impaired due to bankruptcy | | — | | | 171 | | | — | | | 171 | | | — | | | 168 | | | — | | | 168 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total financial assets valued at fair value on a non-recurring basis | | $ | — | | | $ | 931 | | | $ | 742 | | | $ | 1,673 | | | $ | — | | | $ | 792 | | | $ | 58 | | | $ | 850 | |
(1) LHFS disclosed on the Condensed Consolidated Balance Sheets also includes LHFS that are held at the lower of cost or fair value and are presented within the nonrecurring section of this table. (2) Refer to Note 2 for the fair value of investment securities and to Note 13 for the fair values of derivative assets and liabilities on a further disaggregated basis. (3) Certain RICs collateralized by vehicle titles and RV/marine loans. (4) Residential mortgage loans and commercial mortgage loans. (5) Approximately $2.1 billion of these financial assets were measured using model-based techniques, or Level 3 inputs, and represented approximately 6.6% of total assets measured at fair value on a recurring basis and approximately 0.8% of total consolidated assets.
|
| Schedule of Increases and Decreases in Value of Certain Assets Measured at Fair Value on Nonrecurring Basis |
The following table presents the increases and decreases in value of certain assets that are measured at fair value on a nonrecurring basis for which a fair value adjustment has been included in the Condensed Consolidated Statements of Operations relating to assets held at period-end: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | (in millions) | Statement of Operations Location | | 2026 | | 2025 | | 2026 | | 2025 | | | | Impaired LHFI | Credit loss expense / (benefit) | | $ | 23 | | | $ | (8) | | | $ | 38 | | | $ | (9) | | | | | Foreclosed assets | Miscellaneous income, net (1) | | — | | | — | | | 4 | | | (11) | | | | | LHFS | Credit loss expense / (benefit) | | (2) | | | — | | | (2) | | | 9 | | | | | LHFS | Miscellaneous income, net (1) | | — | | | — | | | (4) | | | — | | | | | Auto loans impaired due to bankruptcy | Credit loss expense / (benefit) | | (8) | | | — | | | (7) | | | 4 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1) Gains are disclosed as positive numbers while losses are shown as a negative number regardless of the line item being affected.
|
| Schedule of Quantitative Information on Level 3 Recurring Assets and Liabilities |
The following table presents quantitative information about the significant unobservable inputs within significant Level 3 recurring and nonrecurring assets and liabilities at the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (dollars in millions) | | Fair Value at September 30, 2026 (4) | | Valuation Technique | | Unobservable Inputs | | Range (Weighted Average) | | | | Financial Assets: | | | | | | Beneficial interest in Structured LLC | | $ | 1,013 | | | DCF | | Discount spread | | 2.75% - 25.00% (14.35%) | | | | | | | | | Loss estimate | | 0.00% - 42.64% (6.55%) | | | | | | | | | Extension of loan(1) | | 48 months or 60 months | | | | Equity securities | | 890 | | | Market comparable pricing | | Liquidity discount | | 0.00% - 25.00% (24.00%) | | | | | | | | | Multiples of revenue | | 0.8x - 17.9x (6.8x) | | | | MSRs | | 83 | | | DCF | | CPR (2) | | 6.53% - 37.07% (6.94%) | | | | | | | | | Discount rate (3) | | 9.22 | % | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1) Includes extensions related to workouts and contractual extensions. (2) Average CPR projected from collateral stratified by loan type and note rate. Weighted average amount was developed by weighting the associated relative UPB. (3) Average discount rate from collateral stratified by loan type and note rate. Weighted average amount was developed by weighting the associated relative UPB. (4) Excluded insignificant Level 3 assets and liabilities. NOTE 14. FAIR VALUE (continued)
| | | | | | | | | | | | | | | | | | | | | | | | | | | (dollars in millions) | Fair Value at December 31, 2025 (4) | | Valuation Technique | | Unobservable Inputs | | Range (Weighted Average) | | | | Financial Assets: | | | | | Beneficial interest in Structured LLC | $ | 1,097 | | | DCF | | Discount spread | | 2.75% - 25.00% (13.78%) | | | | | | | | Loss estimate | | 0.00% - 81.33% (6.85%) | | | | | | | | Extension of loan (1) | | 48 or 60 months | | | | Equity securities | $ | 992 | | | Market comparable pricing | | Liquidity discount | | 0.00% - 25.00% (24.00%) | | | | | | | | Multiples of revenue | | 0.8x - 17.9x (3.8x) | | | | MSRs | $ | 80 | | | DCF | | CPR (2) | | 6.48% - 39.82% (7.07%) | | | | | | | | Discount rate (3) | | 9.22 | % | | | | | | | | | | | | |
(1), (2), (3), (4) - See corresponding footnotes to the September 30, 2026 Level 3 significant inputs table above.
|
| Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments |
The carrying amounts and estimated fair values, as well as the level within the fair value hierarchy, of the Company's financial instruments which have not previously been disclosed above are as follows as of the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2026 | | December 31, 2025 | | (dollars in millions) | | Carrying Value | | Fair Value | | Level 1 | | Level 2 | | Level 3 | | Carrying Value | | Fair Value | | Level 1 | | Level 2 | | Level 3 | | Financial assets: | | | | | | | | | | | | | | | | | | | | | | Cash, cash equivalents, and restricted cash | | $ | 30,230 | | | $ | 30,230 | | | $ | 30,230 | | | $ | — | | | $ | — | | | $ | 19,696 | | | $ | 19,696 | | | $ | 19,696 | | | $ | — | | | $ | — | | | Federal funds sold and securities purchased under resale agreements or similar arrangements | | 9,592 | | | 9,572 | | | — | | | 9,572 | | | — | | | 8,640 | | | 8,641 | | | — | | | 8,641 | | | — | | | Investments in debt securities HTM | | 22,584 | | | 20,732 | | | 1,771 | | | 18,961 | | | — | | | 13,212 | | | 11,871 | | | 2,087 | | | 9,784 | | | — | | Equity and other investments (2) | | 936 | | | 936 | | | 41 | | | 5 | | | 890 | | | 997 | | | 997 | | | — | | | 5 | | | 992 | | LHFI, net (3) | | 135,058 | | | 137,215 | | | — | | | 532 | | | 136,683 | | | 76,891 | | | 77,028 | | | — | | | 382 | | | 76,646 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Financial liabilities: | | | | | | | | | | | | | | | | | | | | | Deposits (1) | | 21,032 | | | 21,002 | | | — | | | 21,002 | | | — | | | 15,077 | | | 15,095 | | | — | | | 15,095 | | | — | | | Federal funds purchased and securities loaned or sold under repurchase agreements | | 22,790 | | | 22,772 | | | — | | | 22,772 | | | — | | | 19,460 | | | 19,463 | | | — | | | 19,463 | | | — | | | Borrowings and other debt obligations | | 42,816 | | | 42,790 | | | — | | | 42,408 | | | 382 | | | 37,102 | | | 37,747 | | | — | | | 34,364 | | | 3,383 | |
(1) This line item excludes deposit liabilities with no defined or contractual maturities. (2) This line item includes CDs with a maturity greater than 90 days and equity securities. (3) This line item includes nonrecurring LHFI.
|
| Schedule of Difference Between Fair Value and Principal Balance of LHFS |
The following table summarizes the differences between the fair value and the principal balance of financial instruments measured at fair value on a recurring basis as of the dates indicated: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | September 30, 2026 | | December 31, 2025 | | (in millions) | | Fair Value | | Principal Balance | | Difference | | Fair Value | | Principal Balance | | Difference | LHFS(1) | | $ | 1,685 | | | $ | 1,668 | | | $ | 17 | | | $ | 1,531 | | | $ | 1,484 | | | $ | 47 | | | | | | | | | | | | | | | | RICs HFI | | 3 | | | 3 | | | — | | | 5 | | | 5 | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(1) LHFS disclosed on the Condensed Consolidated Balance Sheets also includes $288 million and $55 million of LHFS valued on a non-recurring basis at September 30, 2026 and December 31, 2025, respectively, that are held at the lower of cost or fair value that are not presented within this table. There were no nonaccrual loans related to the LHFS measured using the FVO.
|